This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: A Valance Washington: Innovator in Platelet Modulation
Introduction
A Valance Washington is a notable inventor based in Bayamon, Puerto Rico. He has made significant contributions to the field of biomedical research, particularly in the modulation of platelet activity. His work has implications for treating various diseases and disorders associated with platelet function.
Latest Patents
Washington holds a patent for "Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions." This invention relates to methods and compositions for modulating platelet activity. It includes administering a single chain anti-TREM-like transcript-1 (TLT-1) antibody or a functional fragment or variant thereof in an effective amount to modulate platelet activity.
Career Highlights
Washington is affiliated with the National Institutes of Health, a component of the U.S. Department of Health & Human Services. His role at this prestigious institution allows him to engage in cutting-edge research that can lead to significant advancements in medical treatments.
Collaborations
Some of his notable coworkers include Toshiyuki Mori and Daniel W. McVicar. Their collaborative efforts contribute to the innovative research environment at the National Institutes of Health.
Conclusion
A Valance Washington's work in platelet modulation represents a vital advancement in biomedical research. His patent and ongoing research efforts have the potential to impact the treatment of diseases related to platelet activity significantly.